These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24597497)

  • 21. Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator.
    Billoir P; Barbay V; Joly LM; Fresel M; Chrétien MH; Le Cam Duchez V
    Ann Pharmacother; 2019 Apr; 53(4):341-347. PubMed ID: 30378443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.
    Tripodi A; Chantarangkul V; Legnani C; Testa S; Tosetto A
    J Thromb Haemost; 2018 Mar; 16(3):565-570. PubMed ID: 29322630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of global laboratory methods and establishing on-therapy ranges for monitoring apixaban and rivaroxaban: Experience at a single institution.
    Park SH; Seo YH; Park PW; Kim KH; Seo JY; Lee HT; Kwoun WJ; Ahn JY
    J Clin Lab Anal; 2019 Jun; 33(5):e22869. PubMed ID: 30860622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.
    Calderone A; Stevens W; Prior D; Nandurkar H; Gabbay E; Proudman SM; Williams T; Celermajer D; Sahhar J; Wong PK; Thakkar V; Dwyer N; Wrobel J; Chin W; Liew D; Staples M; Buchbinder R; Nikpour M
    BMJ Open; 2016 Dec; 6(12):e011028. PubMed ID: 27932335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients.
    Bluecher A; Meyer Dos Santos S; Ferreirós N; Labocha S; Meyer Dos Santos IM; Picard-Willems B; Harder S; Singer OC
    Thromb Haemost; 2017 Feb; 117(3):519-528. PubMed ID: 28124061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.
    Testa S; Legnani C; Tripodi A; Paoletti O; Pengo V; Abbate R; Bassi L; Carraro P; Cini M; Paniccia R; Poli D; Palareti G
    J Thromb Haemost; 2016 Nov; 14(11):2194-2201. PubMed ID: 27566988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apixaban Levels Detected in a Patient 10 Days From Last Known Dose While Experiencing Acute on Chronic Kidney Disease.
    Robinson ZS; Harper NG
    Ann Pharmacother; 2021 May; 55(5):687-688. PubMed ID: 32988217
    [No Abstract]   [Full Text] [Related]  

  • 29. Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH.
    Tripodi A; de Laat B; Wahl D; Ageno W; Cosmi B; Crowther M;
    J Thromb Haemost; 2016 Nov; 14(11):2304-2307. PubMed ID: 27860336
    [No Abstract]   [Full Text] [Related]  

  • 30. Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.
    Ageno W; Crowther M; Baglin T; Falanga A; Buller H; Palareti G;
    J Thromb Haemost; 2013 Jan; 11(1):177-9. PubMed ID: 23419049
    [No Abstract]   [Full Text] [Related]  

  • 31. Practical recommendations on incorporating new oral anticoagulants into routine practice.
    Randhawa J; Thiruchelvam N; Ghobrial M; Spiro T; Clark B; Haddad A; Daw H
    Clin Adv Hematol Oncol; 2014 Oct; 12(10):675-83. PubMed ID: 25658892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory determination of old and new targeted anticoagulant agents for prevention of bleeding and thrombotic events in cancer patients.
    Harenberg J
    Thromb Res; 2016 Apr; 140 Suppl 1():S165-7. PubMed ID: 27067972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prescription and monitoring of anticoagulant therapies].
    Laviolle B; Oger E
    Rev Prat; 2008 Nov; 58(18):2063-70. PubMed ID: 19143281
    [No Abstract]   [Full Text] [Related]  

  • 34. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Apixaban Treatment of TAVR Thrombosis after Warfarin Failure.
    Khan S; Achike O; Nekkanti R; Carabello B
    Cardiology; 2018; 140(4):199-203. PubMed ID: 30138936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apixaban in Venous Thromboembolism in an Era of New Oral Anticoagulants.
    Turagam MK; Velagapudi P; Bongu N; Chinnakotla B; Kocheril A
    Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):139-47. PubMed ID: 26126820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin Anti-Xa Activity, a Readily Available Unique Test to Quantify Apixaban, Rivaroxaban, Fondaparinux, and Danaparoid Levels.
    Boissier E; Senage T; Babuty A; Gouin-Thibault I; Rozec B; Roussel JC; Sigaud M; Ternisien C; Trossaert M; Fouassier M; Lakhal K
    Anesth Analg; 2021 Mar; 132(3):707-716. PubMed ID: 32833716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma.
    Baldelli S; Cattaneo D; Pignatelli P; Perrone V; Pastori D; Radice S; Violi F; Clementi E
    Bioanalysis; 2016 Feb; 8(4):275-83. PubMed ID: 26808218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apixaban Auto-intoxication: Toxicokinetics and Coagulation Tests.
    Mast L; Verheul RJ; Reijnen R; van Rossen RCJM; Overdiek JWPM; Wilms EB
    Thromb Haemost; 2017 Nov; 117(11):2209-2211. PubMed ID: 28981556
    [No Abstract]   [Full Text] [Related]  

  • 40. International collaborative study to establish the World Health Organization 2nd International Standard for Fibrinogen Concentrate (09/242): communication from the SSC of the ISTH.
    Raut S; Hamill M; Heath AB;
    J Thromb Haemost; 2016 Oct; 14(10):2068-2072. PubMed ID: 27660008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.